Join to View Full Profile
555 E Broadway AveSte 229Jackson, WY 83001
Phone+1 307-739-7690
Fax+1 307-739-4970
Dr. Morgan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Capital ConsortiumResidency, Urology, 1994 - 1998- National Capital ConsortiumResidency, Surgery, 1993 - 1994
- National Capital ConsortiumInternship, Transitional Year, 1990 - 1991
Georgetown University School of MedicineClass of 1990
Certifications & Licensure
WY State Medical License 2018 - 2027
MA State Medical License 1991 - 2018
OH State Medical License 2004 - 2008
PA State Medical License 1995 - 2006
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification UroChartEHR, IntrinsiQ Specialty Solutions, Inc. FBO Healthtronics Information Technology Solutions Inc., 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification UroChartEHR, Intuitive Medical Software, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification UroChartEHR, IntrinsiQ Specialty Solutions, Inc. FBO Healthtronics Information Technology Solutions Inc., 2012, 2014-2017
Publications & Presentations
PubMed
- 43 citationsMeasurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer.Gerald P. Murphy, G.M. Kenny, Haakon Ragde, Robert L. Wolfert, Alton L. Boynton
Urology. 1998-05-01 - 24 citationsComparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patientsThomas H. Douglas, Ted O. Morgan, David G. McLeod, Judd W. Moul, Gerald P. Murphy
Cancer. 1997-07-01 - 43 citationsProspective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigenTed O. Morgan, David G. McLeod, Eric S. Leifer, Gerald P. Murphy, Judd W. Moul
Urology. 1996-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
